Vice President of Research

Andrx Pharmaceuticals, Inc.

Guohua Zhang is a vice president of Andrx Pharmaceuticals, Inc. in charge of pharmaceutical R&D. Dr. Zhang received his undergraduate and post-graduate education (B.S. and M.S. in Pharmacy and Pharmaceutics in 1982 and 1984, respectively) from the China Pharmaceutical University and his graduate education (Ph.D. in Pharmaceutics, 1989) from the Philadelphia University of Science. After serving as a Postdoctoral Fellow at Schering-Plough (Kenilworth, New Jersey) from 1989 – 1991, Dr. Zhang joined Pharmaceutical R&D in Hoffman-La Roche as a senior scientist. In 1994, he was hired by Duramed Pharmaceuticals as a director responsible for R&D department, followed by promotion to a vice president in 1996 overseeing Product Development and Analytical R&D. In 1999, Dr. Zhang moved to Andrx as a vice president leading a generic Pharmaceutical R&D. Dr. Zhang is the author or co-author of approximately 50 scientific publications and presentations and the inventor or co-inventor of 6 US patents. Dr. Zhang is one of founders of Sino-American Pharmaceutical Professionals Association (SAPA), Adjunct Professor of the China Pharmaceutical University and Adjunct Professor of Shanghai Institute of Pharmaceutical Industry. His research interests are focused in the area of drug delivery technology and formulation research. Dr, Zhang served SAPA as a vice President for year of 1993-1994, a President for year of 1994-1995, and a member of Advisory Committee thereafter.

Abstract: This presentation summarizes the stories of the birth, growth and prosperity of Sino-American Professionals Association (SAPA) in the last decade. As a witness of this young organization, SAPA has crossed a few important milestones to position herself as one of the greatest professional societies in the mainstream of the pharmaceutical world. SAPA, founded in 1993, has become very influential by promoting pharmaceutical science and technology with the essential roles in fostering member's career development. In the last 10 years, SAPA gradually became a well-recognized organization with a steady growth of the numbers of members, scientific activities, SAPA branches and sponsorship. With the support from all members and the leadership of its EC and AC, SAPA is in a transition stage to become a more mutual organization internationally. In the next decade, SAPA will continue the mission to fulfill its primary purpose and offer vital benefits to the pharmaceutical scientists who constitute its membership.